Products for Research Use Only
RegisterLogin

CDK9-IN-33

CAT: 0013-GTR19262941-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19262941-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK9-IN-33 (compound C35) is a potent, selective, and orally bioavailable CDK9 inhibitor with IC50 values of 17.44 nM for CDK9, 160 nM for CDK7, 316.30 nM for CDK2, 1771.00 nM for CDK4, and >10000 nM for CDK6. This compound induces apoptosis (cell apoptosis) and reduces the protein expression of RPB1 CTD Ser2, RPB1, and MCL1, exhibiting antitumor activity.
Field of Research
Cell Biology, Epigenetics & Chromatin
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19258787-01CDK7-IN-33
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
GTR18187313CDK9 Antibody
GTR19243952-01CDK9-IN-15
GTR19235891-01CDK9-IN-31
GTR19231013-01CDK9-IN-27
GTR19230339-01CDK9-IN-28
GTR19206276-01CDK9-IN-10
GTR19272875-01CDK9-IN-42
GTR17918794-01CDK9 Antibody

Alternative Products

CatalogName
HY-162619CDK9-IN-33
030081CDK9
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
HY-173481CDK9-IN-37
HY-130852-01CDK9-IN-11
70R-10466CDK9 antibody
T205526-01CDK9-IN-36

Popular Products